Retisert

Otitis Externa, Uveitis, Perianal erythema + 30 more

Treatment

2 FDA approvals

20 Active Studies for Retisert

Treatment for

Otitis Externa

What is Retisert

Fluocinolone acetonideThe Generic name of this drug

Treatment SummaryFluocinolone acetonide is a type of corticosteroid that is used in dermatological treatments and to make implantable corticosteroid devices. These devices are made by Taro Pharmaceuticals and have been approved by the FDA since 2016. The formula 6-alpha, 9-alpha-difluoro-16-alpha, 17 alpha-acetonide makes this drug highly lipophilic, or able to dissolve in fat.

Neo-Synalaris the brand name

Retisert Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Neo-Synalar

Fluocinolone acetonide

1963

93

Approved as Treatment by the FDA

Fluocinolone acetonide, otherwise called Neo-Synalar, is approved by the FDA for 2 uses like Uveitis and Uveitis .

Uveitis

Uveitis

Effectiveness

How Retisert Affects PatientsFluocinolone acetonide is a medication used to reduce inflammation. It comes in a form that can be injected directly into the eye, and has been shown to reduce the recurrence of uveitis flares by two times compared to patients not taking it. However, this medication can cause a slight increase in eye pressure, so it is important to monitor your pressure closely.

How Retisert works in the bodyFluocinolone acetonide is a steroid that reduces inflammation in the body. It works by binding to glucocorticoid receptors in the cell nucleus, which then triggers the production of proteins called lipocortins. These lipocortins stop the release of arachidonic acid, which is the precursor to inflammation-causing substances like prostaglandins and leukotrienes. This process reduces inflammation and prevents further damage.

When to interrupt dosage

The recommended dosage of Retisert is contingent upon the determined condition, including Hemorrhoids, Perianal erythema and Itch. The amount of dosage is contingent upon the method of administration (e.g. Kit or Emulsion - Topical) featured in the table below.

Condition

Dosage

Administration

Uveitis

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Secondary Infection

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Anger Management Therapy

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Perianal erythema

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Dermatosis

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Psoriasis of the scalp

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Uveitis

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Uveitis

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Chronic disease

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Skin

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Blisters

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Otitis Media

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Fissure;Anal

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Surgery; Ear

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Anal disorder

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Eczema

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Purulent Wounds

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Ear structure

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Eczema

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Skin Inflammation caused by Bacterial Infections

, 0.0001 mg/mg, 0.1 mg/mL, 0.00025 mg/mg, 0.11 mg/mL, 0.011 mg/mL, 0.0011 mg/mL, 0.01 %, 0.59 mg, 0.025 %, 0.19 mg, 0.0001 mg/mL, 0.25 mg/mL, 1.0 mg/mg, 0.18 mg, 0.625 mg/mL, 0.000003 mg/mg

Topical, , Cream, Cream - Topical, Solution, Solution - Topical, Ointment, Ointment - Topical, Kit, Oil, Auricular (otic), Oil - Auricular (otic), Oil - Topical, Kit - Topical, Solution - Auricular (otic), Intravitreal, Implant - Intravitreal, Implant, Shampoo - Topical, Shampoo, Solution / drops, Solution / drops - Auricular (otic), Gel - Topical, Gel, Emulsion, Emulsion - Topical, Intraocular, Implant - Intraocular

Warnings

Retisert has four prohibitions and should not be taken in combination with the ailments listed in the table below.Retisert Contraindications

Condition

Risk Level

Notes

Mycoses

Do Not Combine

External auditory canal structure

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Fluocinolone Acetonide may interact with conjunctiva

Severe Hypersensitivity Reactions

Do Not Combine

Fluocinolone Acetonide may interact with conjunctiva

There are 20 known major drug interactions with Retisert.

Common Retisert Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abatacept

Major

The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Abatacept.

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Fluocinolone acetonide.

Abetimus

Major

The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Abetimus.

Retisert Toxicity & Overdose RiskStudies have not been conducted to determine the cancer-causing effects or the impact on fertility of taking fluocinolone acetonide. However, other corticosteroids have been shown to cause genetic damage, but tests have found that fluocinolone acetonide does not cause genetic damage.

Retisert Novel Uses: Which Conditions Have a Clinical Trial Featuring Retisert?

97 active clinical trials are currently being conducted to assess the utility of Retisert in alleviating Atopic Dermatitis, Otitis Media and Otitis Externa.

Condition

Clinical Trials

Trial Phases

Perianal erythema

0 Actively Recruiting

Friction and Pressure Injuries

0 Actively Recruiting

Chronic disease

0 Actively Recruiting

Itching

10 Actively Recruiting

Phase 4, Phase 3, Phase 2, Phase 1

Wound Infections

0 Actively Recruiting

Surgery; Ear

0 Actively Recruiting

Seborrheic dermatitis of the scalp

0 Actively Recruiting

Uveitis

0 Actively Recruiting

Hemorrhoids

0 Actively Recruiting

postoperative treatment

0 Actively Recruiting

Ear structure

0 Actively Recruiting

Eczema

0 Actively Recruiting

Blisters

0 Actively Recruiting

Skin Inflammation caused by Bacterial Infections

0 Actively Recruiting

Otitis Externa

0 Actively Recruiting

Postoperative Care

1 Actively Recruiting

Not Applicable

Otitis Media

0 Actively Recruiting

Dermatosis

0 Actively Recruiting

Hemorrhoids

0 Actively Recruiting

Acute Otitis Media (AOM)

3 Actively Recruiting

Not Applicable

Patient Q&A Section about retisert

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How does RETISERT work?

"The Retisert implant is a corticosteroid used to treat inflammation within the eye that may be caused by a variety of diseases or infections. The Retisert implant slowly releases the drug into the eye over a period of approximately 30 months. However, Retisert will not treat an eye infection."

Answered by AI

Who makes retisert?

"Two or more intraocular injections of 0.1 mL (8 mcg) of RETISERT [bimatoprost (r-prostaglandin F2 alpha)] were given 91 to 180 days apart in the study eye of 22 uveitis patients.

In a study of 22 uveitis patients, two or more intraocular injections of 0.1 mL (8 mcg) of RETISERT [bimatoprost (r-prostaglandin F2 alpha)] were given 91 to 180 days apart in the study eye."

Answered by AI

What is Yutiq?

"The YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is a medical device that is used to treat chronic non-infectious uveitis affecting the back of the eye."

Answered by AI

Clinical Trials for Retisert

Image of Detroit Medical Center- Hutzel Women's Hospital in Detroit, United States.

Treatment Group 1. Pre-Intrathecal for Drug-induced itching

This trial aims to study the use of ondansetron, a common anti-nausea medication, in reducing itching and nausea caused by spinal opioids given during cesarean deliveries. The study

Waitlist Available

Detroit Medical Center- Hutzel Women's Hospital

Image of Clinical site 11 in Bryant, United States.

CLE-400 for Notalgia Paresthetica

This trial is testing a new gel called CLE-400 to see if it can help with chronic itching in adults with a condition called Notalgia Paresthetica.

Clinical site 11 (+7 Sites)Clexio Biosciences Ltd.

Image of Oculis Investigative Site - Sierra Eye Associates in Reno, United States.

Dexamethasone ophthalmic suspension (OCS-01) for Diabetic Macular Edema

This trial looks at an eye treatment to help people with diabetes-related vision problems.

Oculis Investigative Site - Sierra Eye AssociatesArshad Khanani, MDOculis

Image of Spencer Center for Vision Research at the Byers Eye Institute in Palo Alto, United States.

Laquinimod for Inflammation

"This trial is testing the safety and effectiveness of using eye drops containing Laquinimod in humans for two weeks."

Spencer Center for Vision Research at the Byers Eye Institute

Have you considered Retisert clinical trials? We made a collection of clinical trials featuring Retisert, we think they might fit your search criteria.

Explore trials for Retisert

Image of Massachusetts Eye Research and Surgery Institution in Waltham, United States.

Ixekizumab for Refractory Uveitis

This trial evaluates a new treatment for certain types of uveitis that haven't responded to other drugs.

Massachusetts Eye Research and Surgery InstitutionC. Stephen Foster, MD, FACS, FACREli Lilly and Company

Image of Children's Hospital of Philadelphia in Philadelphia, United States.

Electronic Data Intervention for Respiratory and Ear Infections

Philadelphia, PA

This trial aims to use electronic data to improve antibiotic use in patients with pneumonia, pharyngitis, and ear infections, and the care provided by clinicians.

Children's Hospital of Philadelphia (+1 Sites)Ebbing Lautenbach, MD, MSCE

Image of California Retina Consultants in Bakersfield, United States.

Foselutoclax for Diabetic Macular Edema

Bakersfield, CA

This trial will test a new drug to treat Diabetic Macular Edema to see if it is effective and safe.

California Retina Consultants (+17 Sites)Sharon Klier, MD, MPHUnity Biotechnology, Inc.

Image of University of Alberta in Edmonton, Canada.

Educational Blogshots for Parenting Health Decisions

Edmonton, Canada

This trial will help determine if blogshots (images summarizing info) are useful for parents to make better healthcare choices for their kids.

Waitlist Available

University of AlbertaLisa Hartling, PhD

Have you considered Retisert clinical trials? We made a collection of clinical trials featuring Retisert, we think they might fit your search criteria.

Explore trials for Retisert

Image of Investigator Site #1069 in Waltham, United States.

ESK-001 for Uveitis

This trial tests a new treatment for eye inflammation in patients with a specific type of eye disease.

Waitlist Available

Investigator Site #1069 (+17 Sites)Alumis Inc

Image of National Ophthalmic Research Institute in Fort Myers, United States.

4D-150 for Diabetic Macular Edema

This trial tests different doses to see if an adult's DME can be treated safely and effectively.

National Ophthalmic Research Institute (+13 Sites)Schonmei Lee, MD4D Molecular Therapeutics

Image of Phoenix, AZ in Phoenix, United States.

EYE103 for Diabetic Eye Conditions

This trial tests a potential drug to help people with vision problems caused by diabetes or macular degeneration. It will assess its safety and effectiveness.

Phoenix, AZ (+25 Sites)EyeBiotech Ltd.

Image of USF Urogynecology Clinic in Tampa, United States.

Timing of Voiding Trials for Postoperative Urinary Retention

This trial is testing if 30 or 60 minutes is best for patients to pass urine after surgery.

USF Urogynecology Clinic

Have you considered Retisert clinical trials? We made a collection of clinical trials featuring Retisert, we think they might fit your search criteria.

Explore trials for Retisert

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security